These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 39197541)

  • 1. MiR-29a-laden extracellular vesicles efficiently induced apoptosis through autophagy blockage in HCC cells.
    Seydi H; Nouri K; Shokouhian B; Piryaei A; Hassan M; Cordani M; Zarrabi A; Shekari F; Vosough M
    Eur J Pharm Biopharm; 2024 Oct; 203():114470. PubMed ID: 39197541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.
    Baldari S; Di Rocco G; Magenta A; Picozza M; Toietta G
    Cells; 2019 Dec; 8(12):. PubMed ID: 31816923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.
    Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W
    Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of
    Huang YH; Lian WS; Wang FS; Wang PW; Lin HY; Tsai MC; Yang YL
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
    Song G; Tian L; Cheng Y; Liu J; Wang K; Li S; Li T
    J Cell Biochem; 2019 Oct; 120(10):18152-18161. PubMed ID: 31190353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma.
    Zhang Y; Yang L; Wang S; Liu Z; Xiu M
    Cancer Biomark; 2018; 22(1):151-159. PubMed ID: 29630527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.
    Xu Y; An Y; Wang Y; Zhang C; Zhang H; Huang C; Jiang H; Wang X; Li X
    Oncol Rep; 2013 May; 29(5):2019-24. PubMed ID: 23483142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mesenchymal stem cells derived extracellular vesicles promote TRAIL-related apoptosis of hepatocellular carcinoma cells via the delivery of microRNA-20a-3p.
    Deng L; Wang C; He C; Chen L
    Cancer Biomark; 2021; 30(2):223-235. PubMed ID: 33136092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
    Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
    Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X
    PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-375 attenuates sorafenib resistance of hepatocellular carcinoma cells by inhibiting cell autophagy.
    Wang D; Yang J
    Acta Biochim Pol; 2023 Apr; 70(2):239-246. PubMed ID: 37068178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
    Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.
    Zhu XC; Dong QZ; Zhang XF; Deng B; Jia HL; Ye QH; Qin LX; Wu XZ
    Int J Mol Med; 2012 Dec; 30(6):1321-6. PubMed ID: 23023935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.